Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05821023 · ClinicalTrials.gov registry record · NA

Messaging Strategies to Reduce Breast Cancer Over-screening in Older Women

A NA study of Breast Cancer Screening, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
4,173
Enrollment target
1
Study location

NCT05821023 is a NA study of Breast Cancer Screening that has completed, run by Johns Hopkins University. The registered enrollment target is 4,173 participants, below the 62,920-participant average among 8 other Breast Cancer Screening trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05821023, a NA study of Breast Cancer Screening, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
4,173 participants
Enrollment target
1
Study location

Study Summary

This is an online survey experiment with data collection over 2 time points two weeks apart. This is Aim 2 of a three-aim R01 project; overall project goal is to better understand how messages from different sources interact to affect older women's breast cancer screening decisions. In this current project, the investigators propose to test the effect of combined exposure to a clinician message + a message from another source (i.e. family/friend or media) on older women's breast cancer screening beliefs, attitudes, and intentions.

Conditions Studied

Interventions

  • OTHER messages

Study Locations (1)

Maryland

  • Johns Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 4,173 participants
Start Date 2023-05-12
Est. Completion 2023-06-19
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT05821023

The ClinicalTrials.gov registry entry for NCT05821023 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4,173 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 62,920-participant average among 8 other Breast Cancer Screening trials with a reported enrollment target (93% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which messages is the first listed.

NCT05821023 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT05821023 about?

NCT05821023 is a clinical study titled "Messaging Strategies to Reduce Breast Cancer Over-screening in Older Women". This is an online survey experiment with data collection over 2 time points two weeks apart. This is Aim 2 of a three-aim R01 project; overall project goal is to better understand how messages from different sources interact to affect older women's breast cancer screening decisions. In this current ...

What is the current status of trial NCT05821023?

This trial is currently completed. It is a NA study. The enrollment target is 4,173 participants. The study started on 2023-05-12. Estimated completion is 2023-06-19.

What conditions does trial NCT05821023 study?

This clinical trial studies the following conditions: Breast Cancer Screening.

What interventions are being tested in trial NCT05821023?

The interventions under investigation include: messages (OTHER).

Who is sponsoring clinical trial NCT05821023?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05821023 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.